EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. (2019)
- Authors:
- Autor USP: BERNARDINO NETO, MORUN - EEL
- Unidade: EEL
- DOI: 10.1200/jco.2019.37.15_suppl.e14518
- Subjects: NEOPLASIAS; TUMOR CARCINOIDE
- Language: Inglês
- Abstract: EGF acts on tumor progression and its receptor can be measured by immunohistochemistry, or in the blood by immunoenzymatic method. This study quantified the expression of blood EGF receptors (bEGFR) in the molecular subtypes of breast carcinoma and their impact on OS.
- Imprenta:
- Publisher place: Alexandria-VA
- Date published: 2019
- Source:
- Título do periódico: Journal of Clinical Oncology
- ISSN: 15277755
- Volume/Número/Paginação/Ano: v.37, n.15, p.e14518-e14518, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ARAUJO, ROGERIO AGENOR DE et al. EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. Journal of Clinical Oncology, v. 37, n. 15, p. e14518-e14518, 2019Tradução . . Disponível em: https://doi.org/10.1200/jco.2019.37.15_suppl.e14518. Acesso em: 30 abr. 2024. -
APA
ARAUJO, R. O. G. E. R. I. O. A. G. E. N. O. R. D. E., ARAÚJO, B. R. E. N. O. J. E. H. A., Silva, M. J. B., Bernardino Neto, M., LUZ, F. E. L. I. P. E. A. N. D. R. É. S. C. O. R. D. E. R. O., DO AMARAL, P. E. D. R. O. A. U. G. U. S. T. O., et al. (2019). EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. Journal of Clinical Oncology, 37( 15), e14518-e14518. doi:10.1200/jco.2019.37.15_suppl.e14518 -
NLM
ARAUJO ROGERIOAGENORDE, ARAÚJO BRENOJEHA, Silva MJB, Bernardino Neto M, LUZ FELIPEANDRÉSCORDERO, DO AMARAL PEDROAUGUSTO, MARINHO EDUARDADACOSTA, NASCIMENTO CAMILAPIQUI, MOSCA ETELVINAROCHA, DELFINO PATRICIAFERREIRARIBEIRO, ANTONIOLI RAFAELMATHIAS, MENDES THAISREZENDE. EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. [Internet]. Journal of Clinical Oncology. 2019 ;37( 15): e14518-e14518.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1200/jco.2019.37.15_suppl.e14518 -
Vancouver
ARAUJO ROGERIOAGENORDE, ARAÚJO BRENOJEHA, Silva MJB, Bernardino Neto M, LUZ FELIPEANDRÉSCORDERO, DO AMARAL PEDROAUGUSTO, MARINHO EDUARDADACOSTA, NASCIMENTO CAMILAPIQUI, MOSCA ETELVINAROCHA, DELFINO PATRICIAFERREIRARIBEIRO, ANTONIOLI RAFAELMATHIAS, MENDES THAISREZENDE. EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. [Internet]. Journal of Clinical Oncology. 2019 ;37( 15): e14518-e14518.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1200/jco.2019.37.15_suppl.e14518 - Saúde Mental, Uso de Álcool e Qualidade do Sono em Estudantes de uma Universidade Pública
- Effects of acute and chronic exercise on the osmotic stability of erythrocyte membrane of competitive swimmers
- The impact of coffee certification on production costs and price paid to the rural producers: a discussion from the viewpoint of transaction cost economics
- Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker
- Influence of erythrocyte membrane stability in atherosclerosis
- Decreased plasma iron levels in women with hyperglycemia are associated with inflammatory status and involve increased HbA1c, osmotic stability, and volume variability of red blood cells
- How effective is the use of glycemic variability in the follow-up of type 1 diabetes under intensive care?
- Swimming reduces fatty acids-associated hypothalamic damage in mice
- 227P The elusive luminal B breast tumor and the mysterious chemokines
- The elusive Luminal B breast cancer and the mysterious chemokines
Informações sobre o DOI: 10.1200/jco.2019.37.15_suppl.e14518 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
